KCNQ2 potassium channel modulators (H Lundbeck)

N/A

Report date: 2025/03/20 15:50:25
NME

Base Information

Drug NameKCNQ2 potassium channel modulators (H Lundbeck)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv7.2 modulators
TargetsVoltage-gated potassium channel subunit Kv7.2
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesNeuro3 Therapeutics Inc
Inactive CompaniesH. Lundbeck A/S
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A